In this episode, Lin Chang, MD, and Jan Tack, MD, PhD, discuss the history and evolution of Rome criteria, developing guidelines for multifactorial disorders in Rome V and more.

· Lin Chang, MD, and Jan Tack, MD, PhD 1:04

· How has the Rome Foundation evolved over the last ten years? 4:26

· What are the Rome criteria, and why should clinicians care about them? 7:20

· How did these guidelines become the Rome criteria? 10:32

· What is the timeline of developing these criteria? 12:35

· Can you tell us about how the Rome Foundation got to the name "DGBI", and why it makes sense for multifactorial conditions? 22:22

· What are the highlights and most important changes from Rome V? 26:38

· How will this information be disseminated so clinicians can learn about it? 34:22

· What lessons did you learn from the Rome V process? 37:40

· What's next for the Rome Foundation? 40:04

Lin Chang, MD, is professor of medicine and vice chief of the Vatche and Tamar Manoukian Division of Digestive Diseases at David Geffen School of Medicine at UCLA.

Jan Tack, MD, PhD, is president of the Rome Foundation. He also serves as professor of medicine at KU Leuven and chief of the division of gastroenterology and hepatology at Leuven University Hospitals.

We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc.

Disclosures: Chey and Tack report no financial disclosures. Chang reports consulting roles with Ardelyx, Atmo, Eli Lilly & Co., FoodMarble, GSK, Ironwood Pharmaceuticals and Ono Pharmaceutical; speaking fees from Bausch Health; research grants from AnX Robotica and Ironwood; serving on the Rome Foundation Board of Directors; and having unvested stock options with FoodMarble, ModifyHealth, PICO Health and Trellus Health.

Reference:

· Drossman DA, et al. Gastroenterology. 2026;doi:10.1053.j.gastro.2026.02.014.

In this episode, Kyle Zebley, CEO of the American Telemedicine Association, or ATA, discusses telemedicine's role in current health policy, innovation in virtual care and more.

· Intro 0:56

· Kyle Zebley 1:03

· What is the distinction between telehealth and telemedicine? 1:37

· Tell us about where you grew up and your upbringing. 2:36

· How did your interest in telehealth and virtual care develop? 7:18

· Was joining the ATA your first shift from working for the government to going into the private sector/a nongovernment role? 11:37

· Is telehealth now evenly distributed throughout the U.S., or are there still areas where it is not being utilized? 16:23

· Discussion on health care worker shortages and issues with distribution, and whether telehealth is part of the solution. 19:10

· Who is pushing back against telehealth? 21:01

· Why can't we get a long-term solution to these issues? 26:11

· Can you share your perspective on the October 2025 government shutdown, and why telehealth flexibility was involved? 30:10

· What are the telehealth innovations that you are most excited about? 35:53

· Is AI-driven technology something the ATA is thinking about and navigating? 41:09

· Thanks for listening 47:28

Kyle Zebley is CEO of the American Telemedicine Association (ATA), leading efforts to advance health care innovation and the transformation of health care through virtual care, digital health and AI-driven models.

We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc.

Disclosures: Berry, Chey and Zebley report no financial disclosures.

In this special podcast episode, Gut Talk host Sameer Berry, MD, interviews his co-host William Chey, MD, to look back at the lessons learned throughout the milestones in his career, and discuss what lies ahead for his year as ACG president.

· Intro 1:11

· Looking back, are there Gut Talk episodes that stand out to you as being particularly memorable? 1:55

· Berry and Chey on common themes in past episodes. 4:46

· Where did you grow up and what were your childhood/early adult years like? 9:19

· Do you think your father being a division chief inspired you? 14:01

· Were there other times your father influenced you? 15:10

· Tell us more about the decisions you have made throughout your training […] Were there other influences that still guide you today? 16:58

· Are there lessons that your mentors left you with in terms of how to be a leader and think creatively? 19:50

· What about guidance you have given as a mentor? […] What advice would you give to those who want to have a leadership career within academics in today's climate? 22:10

· What does the honor of being ACG president mean to you? How did your involvement with the ACG come to be? 26:58

· What does the day-to-day look like as president of the college, and what are some of the key initiatives you are going to work on this year? 30:29

· What are some of the things that excite you most for the future of the college, the GI specialty and the health care industry? 34:26

· Thank you, Bill 37:33

· Thanks for listening 37:55

William D. Chey, MD, AGAF, FACG, is chief and professor in the division of gastroenterology and hepatology at the University of Michigan, where he leads research on diet and nutrition and their impact on functional bowel disorders. He is also co-host of Healio's Gut Talk podcast. Chey is the president of the American College of Gastroenterology (ACG) for the 2025–2026 term.

We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc.

Disclosures: Berry and Chey report no financial disclosures.